Duquesne Family Office's billionaire boss has jettisoned the faces of the artificial intelligence (AI) revolution in favor of a drugmaker whose shares have rallied 191% since the beginning of 2024.

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

Global pharmaceutical leaders Eli Lilly and Novo Nordisk are intensifying competition in Indias rapidly expanding obesity ...

Eli Lilly and Novo Nordisk are in a race to dominate India's booming obesity drug market. They are using aggressive marketing ...

Ajanta Pharma plans to sell generic semaglutide in 26 countries, in a partnership with Biocon, capitalizing on patent ...

FP West: Energy Insider: Go behind the oilpatch's closed doors in our new subscriber-exclusive newsletter. Dozens of ...

SaveHealth reports on popular statin medications that lower cholesterol and cardiovascular risks, highlighting their benefits ...

The revised EU pharmaceutical policy maintains eight-year data protection but reduces market protection to one year, ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

Despite an impending patent cliff in 2026 that will invite generic competition from companies like Sun Pharma and Dr. Reddy's ...

The private label-line is manufactured by drugmaker Perrigo, which is known for its over-the-counter medications for things like allergy and cold medications.

Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...